Send feedback

FOXC1 p.Pro17Ser

c.49C>T · rs1450176374 · VCV2983621

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8817 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00141%, afr)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
Axenfeld-Rieger syndrome type 3

Computational evidence

Protein change
AlphaMissense0.8817likely pathogenic
REVEL0.434indeterminate
SaProtLLR -8.51tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.4GERP 0.96, phastCons 1
Regional constrainto/e 1.07unconstrained · MANE · 355 bp · p 0.32 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00141% African / African-American · 1/71,050 alleles
Filtering AF 8.3e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.6e-05%
Overall 0.000399% 6/1,502,452 alleles · very rare exomes 5/1,350,952 · genomes 1/151,500 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00173% 57,810
African / African-Americangrpmax 0.00141% 71,050
European (non-Finnish) 0.000355% 281,853

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FOXC1
Protein
p.Pro17Ser
Coding
c.49C>T
MANE Select
NM_001453
dbSNP
rs1450176374
Type
single nucleotide variant
Location
chr6:1610494 (GRCh38)
Gene constraint
LOEUF 1.276 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 56.09
Residue 17
the 'required for transcriptional activation' region
Full FOXC1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/foxc1-p-pro17ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown